Skip Navigation

Clear Eyes Recall Issued Due to Risk Eye Drops May Be Contaminated

Clear Eyes Recall Issued Due to Risk Eye Drops May Be Contaminated

Nearly 40,000 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops are being recalled nationwide over concerns that a potential contamination problem may have compromised the sterility of the products, raising the risk of eye infections and other adverse health effects.

The U.S. Food and Drug Administration (FDA) announced the Clear Eyes recall involving eye drops distributed by Medtech Products Inc., part of Prestige Brand Holdings in Tarrytown, New York. According to the FDA enforcement report, the company initiated the recall due to a โ€œlack of assurance of sterilityโ€ after identifying a potential contamination issue affecting certain lots.

The FDA classified the action as a Class II recall, indicating use of the affected eye drops may cause temporary or medically reversible adverse health consequences, although the likelihood of serious health effects is considered remote.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

Clear Eyes Recall

The eye drops recall involves 15 mL bottles of Clear Eyes Maximum Itchy Eye Relief with lot code 2552A and an expiration date of September 30, 2027.

Clear Eyes Maximum Itchy Eye Relief is marketed as an astringent, lubricant and redness reliever intended to ease redness, itching, burning and watery eyes. The product is widely sold through major retailers, including Walmart, Target, CVS, Kroger, Dollar General and Family Dollar.

No other Clear Eyes products are included in the recall, and no injuries have been reported to date. The manufacturer also states that none of the recalled eye drops have been confirmed to be contaminated, indicating the recall was issued out of an abundance of caution.

Consumers are advised to stop using the affected eye drops and return them to the retailer where they were purchased for a full refund. Anyone who experiences symptoms or has concerns about possible side effects should seek medical attention or contact a doctor, healthcare provider or pharmacist for further guidance.

Eye Drop Contamination Lawsuits

Contaminated eye drops have been tied to a series of major recalls and lawsuits in recent years, as failures to maintain sterility may expose users to serious eye infections, vision problems and other potentially permanent injuries.

In March, K.C. Pharmaceuticals issued a sterile eye drop recall affecting more than 3 million bottles sold under several retail brands, including products available at Kroger, Walgreens, CVS and Harris Teeter.

Similar concerns led to a Systane eye drops lawsuit following a December 2024 recall involving potential fungal contamination. The FDA warned that use of the affected products could result in serious health consequences, including eye irritation and potential vision loss.

Individuals who believe they were injured by contaminated or otherwise compromised sterile eye drops may contact a product liability lawyer to investigate whether they may have a claim. There are no fees or expenses unless a recovery is obtained.

Sign up for more legal news that could affect you or your family.

Martha Garcia
Written By: Martha Garcia

Health & Medical Research Writer

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.
A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.

About the writer

Martha Garcia

Martha Garcia

Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers.